Company profile for ACEA Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ACEA Therapeutics is committed to developing and delivering innovative treatments to improve the lives of patients with life-threatening diseases. We believe that a diverse product portfolio is key to our success and ability to bring the right therapy to the right patient at the right time. To that end, we have expanded our drug discovery efforts to encompass development in both targeted and immunotherapy areas. Our lead comp...
ACEA Therapeutics is committed to developing and delivering innovative treatments to improve the lives of patients with life-threatening diseases. We believe that a diverse product portfolio is key to our success and ability to bring the right therapy to the right patient at the right time. To that end, we have expanded our drug discovery efforts to encompass development in both targeted and immunotherapy areas. Our lead compound, Abivertinib, a small molecule kinase inhibitor, is currently under review by the China Food and Drug Administration (CFDA) for the treatment of patients with non-small cell lung cancer (NSCLC).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4224 Campus Point Ct. #210 San Diego, CA 92121
Telephone
Telephone
877.688.1570
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/07/17/2914620/0/en/Scilex-Holding-Company-Announces-Collaboration-to-Leverage-ACEA-Therapeutics-R-D-Expertise-and-Local-Market-Connections-to-Support-the-Expansion-of-ZTlido-Program-in-ex-US-and-Pote.html

GLOBENEWSWIRE
17 Jul 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty